Immuron (IMRN) Interest & Investment Income (2017 - 2024)
Immuron (IMRN) posted Interest & Investment Income of $2184.0 for Q3 2024, down 97.12% on a QoQ basis from $75725.2 in Q4 2023.
Analysis
Immuron (IMRN) Interest & Investment Income (2017 - 2024) Analysis & Trends
Immuron has reported Interest & Investment Income for 8 years, with the latest figure at $2184.0 in Q3 2024.
- On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $2184.0 in Q3 2024; TTM through Sep 2024 was $132056.9, a N/A change from a year earlier, with the FY2026 full-year figure at $185438.0, up 13548.59% from the prior year.
- Interest & Investment Income was $2184.0 for Q3 2024 at Immuron, down from $75725.2 in the prior quarter.
- The five-year high for Interest & Investment Income was $75725.2 in Q4 2023, with the low at $46.26 in Q4 2020.
- Average Interest & Investment Income over 5 years is $26420.6, with a median of $2184.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income jumped 71296.7% in 2022, then jumped 40.05% in 2023.
- Over 5 years, Interest & Investment Income stood at $46.26 in 2020, then soared by 63.71% to $75.73 in 2021, then surged by 71296.7% to $54072.0 in 2022, then surged by 40.05% to $75725.2 in 2023, then plunged by 97.12% to $2184.0 in 2024.
- The last three Interest & Investment Income figures came in at $2184.0 (Q3 2024), $75725.2 (Q4 2023), and $54072.0 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 48.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 67.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 36.92 Mn |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 9, 2024 | 2,183.95 |
| Dec 31, 2023 | 75,725.17 |
| Dec 31, 2022 | 54,072.00 |
| Dec 31, 2021 | 75.73 |
| Dec 31, 2020 | 46.26 |
| Dec 31, 2019 | 2.59 |
| Dec 31, 2018 | 39.00 |
| Dec 31, 2017 | 33.07 |